Explore

Personalized Medicine 2019

11th international conference on Predective preventive and Personalized Medicine & molecular diagnostics 2019

vancouver, Canada
25 - 26 October 2019
The conference ended on 26 October 2019

Important Dates

Abstract Submission Deadline
25th September 2019
Abstract Acceptance Notification
30th September 2019
Final Abstract / Full Paper Deadline
5th October 2019
Early Bird Deadline
10th October 2019

About Personalized Medicine 2019

" Personalized Medicine 2019 will be the world best and the first platform for all the doctors, medical practitioners, students and clinical research organizations to encourage and explore the best referred case reports to infer and strategize novel methodologies in treatment and therapy. The main theme of the conference is “Exploring the New Era of Individualized Treatment Through Science, Technology and Personalized Medicine”World Congress on Personalized Medicine, present & publish your research and meet international collaborators on molecular medicine and personalized diagnostics. "

Topics

Genomics, Microbiology & medicine preventive, Precision medicine

Call for Papers

I kindly request you all to submit your research case or abstract with the title about 300-350 words and biography in 150-200 words along with the photograph. 

 Personalized Medicine  2019 will be the world best and the first platform for all the doctors, medical practitioners, students and clinical research organizations to encourage and explore the best referred case reports to infer and strategize novel methodologies in treatment and therapy. The main theme of the conference is “Exploring the New Era of Individualized Treatment Through Science, Technology and Personalized Medicine”World Congress on Personalized Medicine, present & publish your research and meet international collaborators on molecular medicine and personalized diagnostics.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.